Back to library
PharmaceuticalResearch

Dapoxetine

duh-POS-uh-teen

Research profile · How we handle evidence

Category

Pharmaceutical

Compound type

Phase / Status

Research

Approved in many countries for PE

Standard Dose

30-60mg as needed

As directed

Half-life

1.5 hours

Plasma elimination

Route(s)

OR / IN / TO

Oral, Injectable or Topical

Research Stage

Status Unknown

Research phase not specified; exercise appropriate caution.

Overview

Dapoxetine is an SSRI designed specifically for premature ejaculation. Unlike many antidepressants that are taken daily, it's typically used on-demand, with effects that start relatively quickly and wear off sooner than chronic SSRI regimens. In practice, people often notice side effects early on (like nausea or headache), and those effects may improve as your body adjusts. If you're considering it, follow a clinician's plan rather than self-experimenting - especially if you take other serotonergic medicines.

Plain-language summary

Dapoxetine is an SSRI designed specifically for premature ejaculation. Unlike many antidepressants that are taken daily, it's typically used on-demand, with effects that start relatively quickly and wear off sooner than chronic SSRI regimens. In practice, people often notice side effects early on (like nausea or headache), and those effects may improve as your body adjusts. If you're considering it, follow a clinician's plan rather than self-experimenting - especially if you take other serotonergic medicines.

Administration Routes

  • Oral
  • Injectable
  • Topical

Also known as

PriligyWestoxetinJoypoxDuratiaDapoxSuper P-ForceVriligy

Mechanisms

1

Short-acting SSRI

Detailed mechanism

Dapoxetine inhibits the serotonin reuptake transporter (SERT) with rapid absorption, reaching peak plasma concentrations within 1-2 hours and clearing to sub-therapeutic levels within 24 hours, enabling on-demand rather than chronic daily dosing. By transiently elevating synaptic serotonin in central nervous system pathways - particularly spinal and supraspinal circuits - that regulate ejaculatory latency and reflex threshold, it delays the ejaculatory reflex without the persistent serotonergic burden of conventional SSRIs. Its rapid elimination also minimizes accumulation-related adverse effects and drug interaction windows that would otherwise make as-needed use impractical.

Safety

Side effects

  • Nausea
  • Dizziness
  • Headache
  • Diarrhea

Reported benefits

  • Treats premature ejaculation
  • Fast acting
  • Short duration

Safety profile

Consult medical professional before use

Clinical trials

See research status

Structure

View 3D structure

Verified structure

Dapoxetine

Exact 2D structure can be rendered from a PubChem-backed canonical SMILES string.

Verified via PubChemMatched by casNumber
Source: PubChemLookup: 119356-77-3InChIKey USRHYDPUVLEVMC-FQEVSTJZSA-N
Chemical Formula
C21H23NO
Molecular Weight
305.4 g/mol
CAS Number
119356-77-3
InChIKey
USRHYDPUVLEVMC-FQEVSTJZSA-N

Stack Context

No stack data available.

References

  1. 1

    Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries (Eur Urol)

    2009

    View source
  2. 2

    Dapoxetine for the treatment of premature ejaculation: meta-analysis of randomized controlled trials with trial sequential analysis (J Sex Med)

    2018

    View source
  3. 3

    A double-blind, placebo-controlled Phase 3 study of dapoxetine HCl for premature ejaculation (ClinicalTrials.gov NCT00439335)

    2009

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.